Jump to main content
Jump to site search

Issue 48, 2009
Previous Article Next Article

Novel and emerging approaches for the delivery of metallo-drugs

Author affiliations

Abstract

Cisplatin and its derivatives are the most widely used clinical anticancer agents. They bring enormous benefits to patients but are also associated with unpleasant side-effects because of their abilities to interact with biomolecules other than the target DNA and their broad tissue toxicity across the body. While two molecular re-designs of cisplatin have entered worldwide clinical use (carboplatin and oxaliplatin) and many more have been trialled, these side effects and drawbacks remain. Recently new strategies have been developed to attempt to decrease these side effects and/or modify the tissue activity spectrum through more localized and effective delivery of the drug to the desired targets. In this review we present an overview of the principal approaches that have been explored, ranging from conjugation to biomolecular vectors or polymers, through pro-drug strategies, to adsorption on ceramic materials and encapsulation in macrocycles, nanotubes and nanocapsules, biomolecules and polymers.

Graphical abstract: Novel and emerging approaches for the delivery of metallo-drugs

Back to tab navigation

Publication details

The article was received on 26 Jun 2009, accepted on 08 Oct 2009 and first published on 21 Oct 2009


Article type: Perspective
DOI: 10.1039/B912708A
Dalton Trans., 2009, 10702-10711

  •   Request permissions

    Novel and emerging approaches for the delivery of metallo-drugs

    C. Sanchez-Cano and M. J. Hannon, Dalton Trans., 2009, 10702
    DOI: 10.1039/B912708A

Search articles by author

Spotlight

Advertisements